IBRX IMMUNITYBIO INC
2026Q1 · CUSIP 45256X103 · Sector: Healthcare & Biotech
Lit · Institutions accelerating in
Holders
383
Δ holders QoQ
+110
Breadth percentile
Top 1%
Whale holders
147
Δ whales
+17
Inst. holding value
$1.4B
New positions
147
Closed positions
37
Price momentum (1Q)
+32.9%
Put / Call
20/13
Breadth history (34 quarters)
Past Lit Events & Aftermath 6 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2026Q1 | Top 1% | — | — |
| 2025Q3 | Top 15% | +324.1% | +296.6% |
| 2025Q2 | Top 9% | -14.4% | +251.4% |
| 2024Q2 | Top 8% | +21.4% | -2.7% |
| 2024Q1 | Top 16% | -47.7% | -41.3% |
| 2023Q3 | Top 13% | +15.6% | +72.1% |
Options Sentiment
Put holders
20
QoQ: +14
Call holders
13
QoQ: +8
See methodology →
Fundamentals
PE (TTM)
—
EPS (TTM)
$-0.85
EPS YoY
—
Revenue (TTM)
$0.1B
Revenue YoY
+351.5%
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
As of 2026-03-31 · SEC filings (XBRL)